APEIKON THERAPEUTICS LTD - LONDON
Company Profile | Company Filings |
Overview
APEIKON THERAPEUTICS LTD is a Private Limited Company from LONDON UNITED KINGDOM and has the status: Active.
APEIKON THERAPEUTICS LTD was incorporated 3 years ago on 02/12/2020 and has the registered number: 13057597. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
APEIKON THERAPEUTICS LTD was incorporated 3 years ago on 02/12/2020 and has the registered number: 13057597. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
APEIKON THERAPEUTICS LTD - LONDON
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
71-75 SHELTON STREET
LONDON
WC2H 9JQ
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
25/11/2023 | 09/12/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
OHS SECRETARIES LIMITED | Corporate Secretary | 2023-04-13 | CURRENT | ||
DR MARIA THANOU | Jun 1969 | Greek | Director | 2020-12-02 | CURRENT |
DR MARAL AMRAHLI | Apr 1991 | Azerbaijani | Director | 2023-03-31 | CURRENT |
DR MOH TADAYYON | Sep 1960 | British | Director | 2020-12-02 | CURRENT |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Dr Moh Tadayyon | 2020-12-02 | 9/1960 | London |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Dr Maria Thanou | 2020-12-02 | 6/1969 | London |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Apeikon Therapeutics Ltd | 2024-02-20 | 31-12-2023 | £104,482 Cash |
Apeikon Therapeutics Ltd | 2023-06-17 | 31-12-2022 | £12,481 Cash |
Apeikon Therapeutics Ltd | 2022-08-26 | 31-12-2021 | £100 Cash |